Serascience Limited is a specialist cancer diagnostic company formed to commercialise intellectual property developed at the University of Birmingham. Our innovative products will improve patient management through better diagnostic and prognostic assessment of patients with myeloma and other plasma cell disorders. For the first time patients will be offered point of care (near-patient) testing that will not only allow for more timely therapeutic intervention but will also improve their quality of life and provide efficiencies within health services.

Serascience also supply a broad range of class and subclass specific anti immunoglobulin antibodies. Please visit our online shop to view our list of products.

Online shop